Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,843 | 755 | 97.7% |
| Education | $348.97 | 4 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,269 | 116 | $0 (2024) |
| ABBVIE INC. | $1,403 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,357 | 60 | $0 (2024) |
| PFIZER INC. | $1,315 | 82 | $0 (2024) |
| UCB, Inc. | $1,172 | 80 | $0 (2024) |
| Janssen Biotech, Inc. | $872.64 | 37 | $0 (2024) |
| GENZYME CORPORATION | $765.99 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $739.42 | 40 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $729.21 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $700.64 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,004 | 236 | Amgen Inc. ($798.99) |
| 2023 | $5,030 | 255 | Amgen Inc. ($729.48) |
| 2022 | $3,805 | 210 | Amgen Inc. ($522.68) |
| 2021 | $1,354 | 58 | AbbVie Inc. ($300.15) |
All Payment Transactions
759 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Immunology | ||||||
| 11/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: Immunology | ||||||
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $30.80 | General |
| Category: Immunology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.89 | General |
| 11/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 243 | 405 | $76,795 | $22,490 |
| 2022 | 6 | 172 | 907 | $60,234 | $23,186 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 255 | $68,850 | $20,537 | 29.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 26 | $6,125 | $1,172 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 49 | $980.00 | $411.60 | 42.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 27 | 75 | $840.00 | $368.68 | 43.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 720 | $19,980 | $11,977 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 82 | $22,140 | $6,873 | 31.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 22 | 24 | $8,280 | $2,065 | 24.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 15 | 26 | $4,914 | $1,303 | 26.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 15 | 19 | $4,200 | $861.65 | 20.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 36 | 36 | $720.00 | $106.56 | 14.8% |
About Lisa Beachy, APRN
Lisa Beachy, APRN is a Family healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1073184628.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Beachy, APRN has received a total of $15,192 in payments from pharmaceutical and medical device companies, with $5,004 received in 2024. These payments were reported across 759 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($14,843).
As a Medicare-enrolled provider, Beachy has provided services to 415 Medicare beneficiaries, totaling 1,312 services with total Medicare billing of $45,676. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Oldsmar, FL
- Active Since 07/06/2021
- Last Updated 12/13/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1073184628
Products in Payments
- Enbrel (Biological) $1,409
- XELJANZ (Drug) $1,223
- Cimzia (Drug) $1,076
- RINVOQ (Biological) $1,067
- COSENTYX (Drug) $817.69
- ACTHAR (Biological) $729.21
- BENLYSTA (Biological) $715.14
- OFEV (Drug) $637.33
- KEVZARA (Biological) $633.52
- TALTZ (Drug) $615.58
- TREMFYA (Drug) $608.06
- EVENITY (Biological) $526.72
- ORENCIA (Biological) $514.21
- COSENTYX (Biological) $458.85
- LUPKYNIS (Drug) $421.98
- PURIFIED CORTROPHIN GEL (Drug) $395.53
- SAPHNELO (Biological) $294.54
- SKYRIZI (Biological) $275.28
- KRYSTEXXA (Biological) $242.27
- REMICADE (Biological) $214.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Oldsmar
Elise Helmbrecht
Family — Payments: $3,706
Mr. William Horvath, Aprn, APRN
Family — Payments: $1,671
Edna Wilson, Aprn-C, APRN-C
Family — Payments: $1,582
Mrs. Kimberly Clarke, Arnp, ARNP
Family — Payments: $1,096
Mrs. Gina Vines, Aprn, APRN
Family — Payments: $964.57
Ms. Kyle Maldonado, Arnp, ARNP
Family — Payments: $572.79